The original version of this Article contained an error in the Results section, which incorrectly read 'Erb-sumIL2 did not make any change for tumor control when used after afatinib treatment. However, the administration of afatinib and the Erb-sumIL2 at the same time effectively control tumor growth and prevent tumor development after being rechallenged with a high dose of tumor cells ( Fig. 5f ).' The correct version replaces 'Erb-sumIL2' with 'Her-sumIL2' in two instances. This has been corrected in both the PDF and HTML versions of the Article.
